Australia Dental Soft-Tissue Regeneration Market Size, Share,Trends, Growth Analysis Report, 2029

Name: Australia Dental Soft-Tissue Regeneration Market Size, Share,Trends, Growth Analysis Report, 2029
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Australia Dental Soft-Tissue Regeneration Market analysis

Part of: Dental Soft-Tissue Regeneration Market (Global)

The Australia Dental Soft-Tissue Regeneration Market was valued at $4.2 Million in 2024 and projected to reach to $6.63 Million by 2029, representing a compound annual growth rate of 9.5%. Australia's dental soft-tissue regeneration market is positioned for sustained growth through 2029, driven by increasing patient preference for minimally invasive procedures and rising awareness of regenerative treatment benefits.

Australia Dental Soft-Tissue Regeneration Market (2024-2029) : Size and Share

CAGR of

USD Million

Australia Dental Soft-Tissue Regeneration Market Trends and Insights

This expansion reflects Australia's increasing adoption of advanced regenerative dental technologies and rising demand for minimally invasive periodontal treatments.
Australia's strong healthcare infrastructure and growing patient awareness of soft-tissue restoration options are driving market penetration across major metropolitan centers. The Australian market is benefiting from heightened investment in dental research and development, coupled with favorable reimbursement policies that support regenerative procedures.
Australia's dental professionals are increasingly integrating soft-tissue regeneration solutions into clinical practice, addressing periodontal disease and implant-related complications.
The 9.5% compound annual growth rate through 2029 positions Australia as a significant growth market within the Asia Pacific region, supported by an aging population and rising cosmetic dentistry demand..

Key Market Statistics

CAGR (2024-2029) 9.5% CAGR
Market Size, 2024 ~USD 4.2 Million
Forecast, 2029 ~USD 6.63 Million
Country Australia

Australia Dental Soft-Tissue Regeneration Market Overview

Market Valuation Growth :

Australia's dental soft-tissue regeneration market is valued at $4.2 million in 2024, with a projected CAGR of 9.5% through 2029, reaching $6.63 million. This outpaces the global CAGR of 7.8%, indicating strong regional momentum.

Advanced Healthcare Infrastructure :

Australia's robust healthcare system and high dental care standards create an ideal environment for adoption of cutting-edge regenerative technologies, supported by strong regulatory frameworks and professional dental associations.

Rising Patient Awareness :

Growing consumer demand for minimally invasive periodontal treatments and aesthetic dental solutions is driving market expansion across Australian dental practices and specialist clinics.

Technology Adoption Trends :

Australian dental professionals are increasingly integrating regenerative soft-tissue solutions into treatment protocols, reflecting broader adoption of advanced dental biotechnology and regenerative medicine practices.

Australia Dental Soft-Tissue Regeneration Market Dynamics

The country's advanced healthcare infrastructure and high dental care standards support rapid technology adoption among practitioners.
Growing investment in dental research and development, combined with favorable reimbursement policies, creates a conducive environment for market expansion.
Australian dental clinics are increasingly incorporating soft-tissue regeneration solutions into their service offerings, responding to patient demand for superior aesthetic and functional outcomes in periodontal and implant treatments..

Related Ecosystem

Medical Devices

Top Technologies

Polymerase Chain Reaction (PCR)
Magnetic Resonance Imaging (MRI)
Disposable Autoinjectors
Pulse Oximeters
Blood Pressure Monitors

Top Companies

Medtronic plc
Abbott Laboratories
Stryker Corporation
Becton, Dickinson and Company
JOHNSON & JOHNSON

Key Takeaways

Australia's dental soft-tissue regeneration market is valued at $4.2 million in 2024 and is forecast to reach $6.63 million by 2029, representing a 9.5% CAGR.
Australia's advanced healthcare infrastructure and strong regulatory framework support rapid adoption of regenerative dental technologies.
Growing patient demand for minimally invasive periodontal treatments and cosmetic dentistry is accelerating market expansion across Australia.
Australia's aging demographic profile and increasing prevalence of periodontal disease are key drivers of soft-tissue regeneration market growth.

Dental Soft-Tissue Regeneration Market Report Scope

Report Metric	Details
Base Year	2024
Fastest Growing Segment	PERIODONTOLOGY (Application)
Forecast Period	2024�2029
Growth Rate	CAGR of 7.8% from 2024 to 2029
Largest Segment	AUTOGRAFTS (Product Type)
Market Size Base Year (Billions)	~USD 0.34 (2024)
Revenue Forecast (Billions)	~USD 0.54 (2029)
Segments Covered	Product Type, Application, End User

Australia Dental Soft-Tissue Regeneration Market Report Segmentation

3 segment dimensions are covered across the global market.

By Product Type

Autografts
Collagen-Based Membranes
Other Products
Synthetic Biomaterials

By Application

Implantology
Other Applications
Periodontology

By End User

Academic & Research Institutes
Dental Hospitals
Dsos & Independent Clinics

AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022�2029

Segment	2022	2023	2024	2025	2026	2027	2028	2029	CAGR (%)
ACADEMIC & RESEARCH INSTITUTES	0.45	0.46	0.47	0.48	0.5	0.52	0.55	0.59	4.6
DENTAL HOSPITALS	2.13	2.22	2.33	2.47	2.64	2.85	3.11	3.43	8
DSOS & INDEPENDENT CLINICS	3.87	4.08	4.36	4.68	5.08	5.56	6.14	6.87	9.5
TOTAL	6.45	6.75	7.16	7.64	8.22	8.93	9.8	10.88	8.7

Target Audience

Dental Device Manufacturers : Manufacturers need Australia-specific market data to assess market entry opportunities, competitive landscape, and growth potential for soft-tissue regeneration products in this high-value regional market.
Dental Practice Operators : Practice owners and managers require insights into patient demand trends, treatment adoption rates, and revenue opportunities to justify investment in regenerative dental technologies and service expansion.
Healthcare Investors & PE Firms : Investment professionals need detailed market sizing, growth projections, and competitive analysis specific to Australia to evaluate acquisition targets and portfolio companies in the dental regeneration sector.
Dental Specialists & Periodontists : Clinical practitioners need market intelligence on emerging technologies, patient preferences, and treatment trends to stay competitive and make informed decisions about adopting new regenerative solutions.
Healthcare Consultants & Advisors : Consulting firms require Australia-specific market data and forecasts to support strategic planning, market entry strategies, and business development initiatives for healthcare clients in the dental sector.

Key Companies in the Australia Dental Soft-Tissue Regeneration Market

Company	HQ	Ownership	Strongest segments
HENRY SCHEIN, INC.	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ENVISTA	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ZIMVIE INC.	United States	Private Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
DENTSPLY SIRONA INC.	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ABBVIE INC.	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ADVANCED MEDICAL SOLUTIONS GROUP PLC	United Kingdom	Public Company	Collagen-based Membranes,Synthetic Biomaterials,Autografts,
TISSUE REGENIX	United Kingdom	Private Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
MECCELLIS BIOTECH	France		Collagen-based Membranes,Synthetic Biomaterials,Autografts,

HENRY SCHEIN, INC.

Henry Schein, Inc. is a publicly traded American company founded in 1932 with approximately 25,000 employees. It is a leading global distributor of dental, medical, and veterinary products and services.

ENVISTA

Envista is a publicly traded American company founded in 2018 with approximately 12,000 employees. The company operates as a global provider of dental products, technologies, and services.

ZIMVIE INC.

Zimvie Inc. is a privately held American company founded in 2021 with approximately 1,770 employees. The company focuses on dental implants, bone regeneration, and related surgical solutions.

DENTSPLY SIRONA INC.

Dentsply Sirona Inc. is a publicly traded American company founded in 2015. The company is a leading manufacturer and distributor of dental products, technologies, and equipment.

ABBVIE INC.

AbbVie Inc. is a publicly traded American pharmaceutical company founded in 2012 with approximately 57,000 employees. The company develops and markets a broad range of pharmaceutical products across multiple therapeutic areas.

ADVANCED MEDICAL SOLUTIONS GROUP PLC

Advanced Medical Solutions Group PLC is a publicly traded British company founded in 1991 with approximately 1,800 employees. The company specializes in advanced wound care and surgical solutions.

TISSUE REGENIX

Tissue Regenix is a privately held British company founded in 2006 with approximately 92 employees. The company develops regenerative medicine and advanced wound care products.

MECCELLIS BIOTECH

Meccellis Biotech is a French company founded in 2011 that operates in the biotechnology sector. The company focuses on regenerative medicine and cellular therapy solutions.

Reasons to Buy this Report

Market-Specific Growth Insights : Gain detailed understanding of Australia's 9.5% CAGR trajectory and competitive positioning relative to global markets, enabling informed investment and expansion decisions in this high-growth regional segment.
Regulatory & Reimbursement Landscape : Access comprehensive analysis of Australian healthcare policies, TGA regulations, and insurance coverage frameworks that directly impact market accessibility and commercial viability for regenerative dental solutions.
Competitive Positioning Strategy : Identify key Australian market players, emerging competitors, and partnership opportunities to develop targeted go-to-market strategies and establish competitive advantages in this specialized dental segment.
Clinical Adoption Patterns : Understand adoption rates among Australian dental practitioners, specialist preferences, and clinical practice trends to optimize product development and marketing strategies for local market penetration.
Patient Demand & Demographic Insights : Leverage Australia-specific patient demographics, treatment preferences, and willingness-to-pay data to refine pricing strategies and develop targeted marketing campaigns for maximum market impact.

Frequently asked questions

What is the current market size of dental soft-tissue regeneration in Australia?

Australia's dental soft-tissue regeneration market was valued at $4.2 million in 2024 and is expected to grow to $6.63 million by 2029.

What is the projected growth rate for Australia's dental soft-tissue regeneration market?

Australia's market is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2029.

What factors are driving growth in Australia's dental soft-tissue regeneration market?

Key drivers include Australia's aging population, rising prevalence of periodontal disease, increasing patient awareness of regenerative treatments, and strong healthcare infrastructure supporting technology adoption.

How does Australia's market compare to the global dental soft-tissue regeneration market?

Australia's 9.5% CAGR outpaces the global market growth rate of 7.8%, positioning Australia as a high-growth region within the Asia Pacific segment.

What types of soft-tissue regeneration procedures are most common in Australia?

Australia's market encompasses guided tissue regeneration, bone grafting, soft-tissue grafts, and biologics-based solutions for periodontal disease and implant-related complications.

RESEARCH METHODOLOGY

This study involved four key activities to estimate the current size of the dental soft-tissue regeneration market. First, extensive secondary research was conducted to gather information about the market, as well as related markets and the overall parent market. Next, the findings, assumptions, and estimates were validated through primary research conducted with industry experts across the value chain. Both top-down and bottom-up approaches were utilized to determine the overall market size. Finally, market breakdown and data triangulation techniques were employed to estimate the sizes of various segments and subsegments.

Secondary Research

The secondary research process utilized a variety of sources, including directories and databases such as Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company documents, investor presentations, and SEC filings. This method was employed to gather information relevant to a comprehensive, technical, market-focused, and commercial analysis of the dental soft-tissue regeneration market. It also helped obtain crucial details about key players in the industry, market classification, and segmentation based on current trends, extending down to the most granular levels. Additionally, important developments related to market and technological perspectives were captured. A database of key industry leaders was created using the information collected through secondary research.

Primary Research

In the primary research process, a variety of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from important companies and organizations operating in the dental soft-tissue regeneration market. On the demand side, primary sources consisted of industry experts, purchasing and sales managers, doctors, and personnel from research organizations. This primary research aimed to validate market segmentation, identify key players, and collect insights on major industry trends and market dynamics.

A breakdown of the primary respondents for the dental soft-tissue regeneration market is provided below:

Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.

Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global dental soft-tissue regeneration market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global dental soft-tissue regeneration market was split into various segments and subsegments based on:

List of major players operating in the products market at the regional and/or country level
Product mapping of various dental soft-tissue regeneration manufacturers at the regional and/or country level
Mapping of annual revenue generated by listed major players from dental soft-tissue regenerative products (or the nearest reported business unit/product category)
Revenue mapping of major players to cover at least 70–75% of the global market share as of 2023
Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
Summation of the market value of all segments/subsegments to arrive at the global diagnostics market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation (Bottom-up Approach & Top-down Approach)

Data Triangulation

After arriving at the overall size of the global dental soft-tissue regeneration market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.

Market Definition

Dental soft-tissue regeneration involves restoring or reconstructing soft tissues, including the gums and connective tissues surrounding the teeth. This process seeks to facilitate the healing of tissues lost due to gum disease or trauma to enhance the health and aesthetic appearance of the gums and their functionality. These procedures can be effectively used in the treatment of gum recession, tissue defects around the implants, or any other soft-tissue defects, and eventually, to improve the smile.

Stakeholders

Dental soft-tissue regenerative material manufacturing companies
Distributors and suppliers of dental soft-tissue regeneration products
Medical device companies
Research and consulting firms
Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
Research institutes and academic centers
Contract research organizations (CROs)
Government associations
Venture capitalists and investors

Report Objectives

To define, describe, and forecast the dental soft-tissue regeneration market based on product type, application, end user, and region
To forecast the market size based on six key regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, Porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events
To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall dental soft-tissue regeneration market
To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
To strategically profile key players in the dental soft-tissue regeneration market and comprehensively analyze their core competencies
To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall dental soft-tissue regeneration market
To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
To analyze the generative AI impact on the dental soft-tissue regeneration market

Get the Full Dental Soft-Tissue Regeneration Market Report

Full forecast, segment splits, and company analysis for all Dental Soft-Tissue Regeneration Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)